Pipofezine

See also

References

1. ^ Aleeva GN, Molodavkin GM, Voronina TA (July 2009). "Comparison of antidepressant effects of azafan, tianeptine, and paroxetine". Bulletin of Experimental Biology and Medicine. 148 (1): 54–56. doi:10.1007/s10517-009-0638-4. PMID 19902096. S2CID 23923093.
2. ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 843. ISBN 3-88763-075-0.
3. ^ Muller NF, Dessing RP (1998). European Drug Index, 4th Edition. Boca Raton: CRC Press. p. 126. ISBN 3-7692-2114-1.
4. ^ Macor JE (2009). Annual Reports in Medicinal Chemistry, Volume V44. Boston: Academic Press. p. 16. ISBN 978-0-12-374766-2.
5. ^ Mashkovskii MD, Polezhaeva AI, Avrutskii GI, Vertozgadova OP, Smulevich AB (1969). "[The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen]". Zhurnal Nevropatologii I Psikhiatrii imeni S.S. Korsakova (in Russian). 69 (8): 1234–1238. PMID 5392529.
6. ^ Shinaev NN, Akzhigitov RG (2005). "[Azaphen: a return to clinical practice]". Zhurnal Nevrologii I Psikhiatrii imeni S.S. Korsakova (in Russian). 105 (10): 55–56. PMID 16281382.
7. ^ Avdulov NA, Maĭsov NI (November 1981). "[Atypical antidepressants: effect on synaptosomal uptake of serotonin and GABA]". Biulleten' Eksperimental'noi Biologii I Meditsiny (in Russian). 92 (11): 564–566. PMID 7198493.
8. ^ Valdman AV, Avdulov NA, Rozganets VV, Rusacov DY (1983). "Behavioural and neurochemical studies of the action of atypical antidepressants". Acta Physiologica et Pharmacologica Bulgarica. 9 (3): 3–10. PMID 6142583.
9. ^ Macor JE (2009). Annual Reports in Medicinal Chemistry, Volume V44. Boston: Academic Press. ISBN 978-0-12-374766-2.